PROGRAM CHAIR
Patricia Coyle, MD, FAAN, FANA
Professor and Interim Chair of Neurology
Director MS Comprehensive Care Center
Stony Brook Renaissance School of Medicine
Stony Brook, NY
PROGRAM CO-CHAIR
Ulrike W Kaunzner, MD
Assistant Professor of Neurology
Director of Neurology Clinic
Director of MS Fellowship Program
Weill Cornell Medicine
New York, NY
PROGRAM OVERVIEW
This educational program focuses on updates in the management of multiple sclerosis and takes a closer look at therapies, quality of life, and safety data. Through an online enduring educational snapshot program, an ECHO Whiteboard TeleECHO series, a smart reach replay of a Whiteboard TeleECHO session, SmartCast™ microlearning podcast series, and point-of-care tools, healthcare practitioners will discuss the burden of multiple sclerosis, including both relapsing and primary progressive forms of the disease, review industry-standard practices for diagnosis and continual assessment of disease course of action, as well as the patient’s functionality, and quality of life. This program will also outline current clinical efficacy and safety data and best practices for evidence-based use of current therapies.
TARGET AUDIENCE
This activity is designed to meet the educational needs of neurologists and other healthcare professionals, such as psychiatrists, primary care clinicians, pharmacists, nurse practitioners, and physician assistants, to ensure confidence in the assessment and multidisciplinary management of multiple sclerosis.
LEARNING OBJECTIVES
- Discuss the burden of multiple sclerosis, including both relapsing and primary progressive forms of disease
- Implement current best practices for diagnosis and continual assessment of disease activity, function, and quality of life in multiple sclerosis
- Evaluate current clinical efficacy and safety data with multiple sclerosis therapeutics and best practices for evidence-based use of current therapies
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually enduring activity for a maximum of .5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of .5 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Patricia Coyle, MD | Consulting Fees | Accordant, Biogen, Bristol Myers Squibb, GlaxoSmithKline, Genentech, Horizon Therapeutics, LabCorp, Eli Lilly and Company, Mylan, Novartis, Sanofi Genzyme, and TG Therapeutics |
| Contracted Research | Actelion, Alkermes, Celgene, CorEvitas LLC, Genentech/Roche, Janssen, MedDay Pharma, NINDS, Novartis, and Sanofi Genzyme | |
| Ulrike W. Kaunzner, MD | Consulting Fees | Novartis |
| Contracted Research | Genetech (PI initiated study, funding to Cornell) |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity: Matthew
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Lisa Kuhns, Medical Director for Med Learning Group, has nothing to disclose.
- Melissa A. Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.
- Millena De Brito, Program Coordinator for Med Learning Group has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at [email protected]
RELEASED DATE: February 23, 2024
EXPIRATION DATE: February 23, 2025
Copyright ©2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
